Reckitt to Pay $1.4 Billion to End U.S. Opioid Treatment Probe

(Bloomberg) -- Reckitt Benckiser Group Plc agreed to pay as much as $1.4 billion to settle an investigation into the sales and marketing of a treatment for opioid addiction by former unit Indivior ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.